Highlight
- Large cohort study compares pregnancy outcomes between biologic-exposed and unexposed psoriasis patients.
- Biologic exposure during pregnancy did not increase risk of adverse pregnancy outcomes (APOs).
- Lower odds of spontaneous abortion and gestational diabetes were observed in biologic-exposed patients.
- Findings support the relative safety of biologic therapy for managing psoriasis during pregnancy.
Study Background
